These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 16244283)

  • 21. Chronic thrombus detection with in vivo magnetic resonance imaging and a fibrin-targeted contrast agent.
    Sirol M; Fuster V; Badimon JJ; Fallon JT; Moreno PR; Toussaint JF; Fayad ZA
    Circulation; 2005 Sep; 112(11):1594-600. PubMed ID: 16145001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multipolar radiofrequency ablation of hepatic tumors: initial experience.
    Frericks BB; Ritz JP; Roggan A; Wolf KJ; Albrecht T
    Radiology; 2005 Dec; 237(3):1056-62. PubMed ID: 16237132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic resonance imaging of the breast in evaluating residual diseases at lumpectomy site soon after excisional biopsy.
    Yang H; Liu H; Peng W; Hua Y
    J Comput Assist Tomogr; 2012; 36(2):196-9. PubMed ID: 22446359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is gadoxetate disodium-enhanced MRI useful for detecting local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy?
    Watanabe H; Kanematsu M; Goshima S; Yoshida M; Kawada H; Kondo H; Moriyama N
    AJR Am J Roentgenol; 2012 Mar; 198(3):589-95. PubMed ID: 22357997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracranial tumor in children: MR imaging findings within 24 hours of craniotomy.
    Oser AB; Moran CJ; Kaufman BA; Park TS
    Radiology; 1997 Dec; 205(3):807-12. PubMed ID: 9393539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gd-DTPA-enhanced MR imaging in mediastinal Hodgkin's disease.
    Forsgren G; Nyman R; Glimelius B; Hagberg H; Rehn S; Hemmingsson A
    Acta Radiol; 1994 Nov; 35(6):564-9. PubMed ID: 7946679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intercellular imaging by a polyarginine derived cell penetrating peptide labeled magnetic resonance contrast agent, diethylenetriamine pentaacetic acid gadolinium.
    Guo YM; Liu M; Yang JL; Guo XJ; Wang SC; Duan XY; Wang P
    Chin Med J (Engl); 2007 Jan; 120(1):50-5. PubMed ID: 17254488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Focal liver lesions: SPIO-, gadolinium-, and ferucarbotran-enhanced dynamic T1-weighted and delayed T2-weighted MR imaging in rabbits.
    Schnorr J; Wagner S; Abramjuk C; Drees R; Schink T; Schellenberger EA; Pilgrimm H; Hamm B; Taupitz M
    Radiology; 2006 Jul; 240(1):90-100. PubMed ID: 16684917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gadolinium-enhanced MR imaging of renal masses.
    Rominger MB; Kenney PJ; Morgan DE; Bernreuter WK; Listinsky JJ
    Radiographics; 1992 Nov; 12(6):1097-116; discussion 1117-8. PubMed ID: 1439014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Gd [DTPA-bis (2-aminoethoxy) ethane] polymeric contrast agent with gadodiamide injection for interstitial MR lymphography: experimental study with rabbits.
    Zhou Z; Guo J; Yu H; Zhu B; Liu C; Jiang X; Zhang M; Chen J
    J Magn Reson Imaging; 2005 Sep; 22(3):361-7. PubMed ID: 16106365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic Gd-DTPA-enhanced MR imaging of the kidney: experimental results.
    Choyke PL; Frank JA; Girton ME; Inscoe SW; Carvlin MJ; Black JL; Austin HA; Dwyer AJ
    Radiology; 1989 Mar; 170(3 Pt 1):713-20. PubMed ID: 2916025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noninvasive measurement of renal hemodynamic functions with gadolinium-enhanced MR imaging.
    Katzberg RW
    Radiology; 1999 Jan; 210(1):287-8. PubMed ID: 9885625
    [No Abstract]   [Full Text] [Related]  

  • 33. Correlating subcellular contrast agent location from dynamic contrast-enhanced magnetic resonance imaging (dMRI) and analytical electron microscopy.
    Noseworthy MD; Ackerley C; Qi X; Wright GA
    Acad Radiol; 2002 Aug; 9 Suppl 2():S514-8. PubMed ID: 12188325
    [No Abstract]   [Full Text] [Related]  

  • 34. Investigation of MR contrast media utility with the VX-2 tumor model.
    Runge VM; Williams NM
    Acad Radiol; 1998 Apr; 5 Suppl 1():S34-6; discussion S45-6. PubMed ID: 9561038
    [No Abstract]   [Full Text] [Related]  

  • 35. Case 179: Hereditary hemochromatosis.
    Sondag MJ; Wattamwar AS; Aleppo G; Nemeth AJ
    Radiology; 2012 Mar; 262(3):1037-41. PubMed ID: 22357904
    [No Abstract]   [Full Text] [Related]  

  • 36. Hepatic Radiofrequency Ablation: Monitoring of Ablation-Induced Macrophage Recruitment in the Periablational Rim Using SPION-Enhanced Macrophage-Specific Magnetic Resonance Imaging.
    Collettini F; Brangsch J; Reimann C; Chapiro J; Savic LJ; Buchholz R; Keller S; Hamm B; Goldberg SN; Makowski MR
    Invest Radiol; 2021 Sep; 56(9):591-598. PubMed ID: 33787536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic pitfalls and artifacts in abdominal MR imaging: a review.
    Mirowitz SA
    Radiology; 1998 Sep; 208(3):577-89. PubMed ID: 9722832
    [No Abstract]   [Full Text] [Related]  

  • 38. Residual or Retained Gadolinium.
    Ben Salem D; Ognard J; Guiu B
    Radiology; 2016 Nov; 281(2):650-651. PubMed ID: 27755932
    [No Abstract]   [Full Text] [Related]  

  • 39. How to best assess ablation lesion formation with late gadolinium enhancement MRI.
    Althoff TF; Mont L
    J Cardiovasc Electrophysiol; 2020 Nov; 31(11):3067-3068. PubMed ID: 32964559
    [No Abstract]   [Full Text] [Related]  

  • 40. Report on the ISMRM-ESMRMB 2022 hot topic debate on the future of gadolinium as a contrast agent.
    Quattrocchi CC; Agarwal N; Taso M; Dekkers IA
    MAGMA; 2022 Oct; 35(5):707-710. PubMed ID: 35767161
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.